These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 21673065)

  • 1. To DNA or not to DNA? That is the question, when it comes to molecular subtyping for the clinic!
    Smeets SJ; Harjes U; van Wieringen WN; Sie D; Brakenhoff RH; Meijer GA; Ylstra B
    Clin Cancer Res; 2011 Aug; 17(15):4959-64. PubMed ID: 21673065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA copy number alterations and expression of relevant genes in triple-negative breast cancer.
    Han W; Jung EM; Cho J; Lee JW; Hwang KT; Yang SJ; Kang JJ; Bae JY; Jeon YK; Park IA; Nicolau M; Jeffrey SS; Noh DY
    Genes Chromosomes Cancer; 2008 Jun; 47(6):490-9. PubMed ID: 18314908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer.
    Bergamaschi A; Kim YH; Wang P; Sørlie T; Hernandez-Boussard T; Lonning PE; Tibshirani R; Børresen-Dale AL; Pollack JR
    Genes Chromosomes Cancer; 2006 Nov; 45(11):1033-40. PubMed ID: 16897746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The genomic relationship between primary breast carcinomas and their nodal metastases.
    Desouki MM; Liao S; Conroy J; Nowak NJ; Shepherd L; Gaile DP; Geradts J
    Cancer Invest; 2011 May; 29(4):300-7. PubMed ID: 21469979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microarray comparative genomic hybridization analysis of tubular breast carcinoma shows recurrent loss of the CDH13 locus on 16q.
    Riener MO; Nikolopoulos E; Herr A; Wild PJ; Hausmann M; Wiech T; Orlowska-Volk M; Lassmann S; Walch A; Werner M
    Hum Pathol; 2008 Nov; 39(11):1621-9. PubMed ID: 18656243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic alterations and oncogenic pathways associated with breast cancer subtypes.
    Hu X; Stern HM; Ge L; O'Brien C; Haydu L; Honchell CD; Haverty PM; Peters BA; Wu TD; Amler LC; Chant J; Stokoe D; Lackner MR; Cavet G
    Mol Cancer Res; 2009 Apr; 7(4):511-22. PubMed ID: 19372580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of DNA copy number alterations and prognostic gene expression signatures in breast cancer patients.
    Horlings HM; Lai C; Nuyten DS; Halfwerk H; Kristel P; van Beers E; Joosse SA; Klijn C; Nederlof PM; Reinders MJ; Wessels LF; van de Vijver MJ
    Clin Cancer Res; 2010 Jan; 16(2):651-63. PubMed ID: 20068109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A gene expression signature identifies two prognostic subgroups of basal breast cancer.
    Sabatier R; Finetti P; Cervera N; Lambaudie E; Esterni B; Mamessier E; Tallet A; Chabannon C; Extra JM; Jacquemier J; Viens P; Birnbaum D; Bertucci F
    Breast Cancer Res Treat; 2011 Apr; 126(2):407-20. PubMed ID: 20490655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-resolution genomic profiling reveals association of chromosomal aberrations on 1q and 16p with histologic and genetic subgroups of invasive breast cancer.
    Stange DE; Radlwimmer B; Schubert F; Traub F; Pich A; Toedt G; Mendrzyk F; Lehmann U; Eils R; Kreipe H; Lichter P
    Clin Cancer Res; 2006 Jan; 12(2):345-52. PubMed ID: 16428471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonfamilial breast cancer subtypes.
    Ringnér M; Staaf J; Jönsson G
    Methods Mol Biol; 2013; 973():279-95. PubMed ID: 23412797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prognostic DNA signature for T1T2 node-negative breast cancer patients.
    Gravier E; Pierron G; Vincent-Salomon A; Gruel N; Raynal V; Savignoni A; De Rycke Y; Pierga JY; Lucchesi C; Reyal F; Fourquet A; Roman-Roman S; Radvanyi F; Sastre-Garau X; Asselain B; Delattre O
    Genes Chromosomes Cancer; 2010 Dec; 49(12):1125-34. PubMed ID: 20842727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA sequence losses on chromosomes 11p and 18q are associated with clinical outcome in lymph node-negative ductal breast cancer.
    Dellas A; Torhorst J; Schultheiss E; Mihatsch MJ; Moch H
    Clin Cancer Res; 2002 May; 8(5):1210-6. PubMed ID: 12006540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-resolution genomic profiling to predict 10-year overall survival in node-negative breast cancer.
    Möllerström E; Delle U; Danielsson A; Parris T; Olsson B; Karlsson P; Helou K
    Cancer Genet Cytogenet; 2010 Apr; 198(2):79-89. PubMed ID: 20362222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic change of chromosome 8 predicts the response to taxane-based neoadjuvant chemotherapy in node-positive breast cancer.
    Han S; Park K; Shin E; Kim HJ; Kim JY; Kim JY; Gwak G
    Oncol Rep; 2010 Jul; 24(1):121-8. PubMed ID: 20514452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copy number alterations that predict metastatic capability of human breast cancer.
    Zhang Y; Martens JW; Yu JX; Jiang J; Sieuwerts AM; Smid M; Klijn JG; Wang Y; Foekens JA
    Cancer Res; 2009 May; 69(9):3795-801. PubMed ID: 19336569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic applications of gene expression signatures in breast cancer.
    Normanno N; De Luca A; Carotenuto P; Lamura L; Oliva I; D'Alessio A
    Oncology; 2009; 77 Suppl 1():2-8. PubMed ID: 20130425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic molecular classification of breast cancers based on gene expression profiling].
    Feng YM; Li XQ; Sun BC; Gao XC; Gu L; Niu Y; Hao XS
    Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):900-6. PubMed ID: 17533740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of chromosomal aberrations in breast cancer by comparative genomic hybridization (CGH). Correlation with histoprognostic variables and c-erbB-2 immunoexpression.
    Malamou-Mitsi VD; Syrrou M; Georgiou I; Pagoulatos G; Agnantis NJ
    J Exp Clin Cancer Res; 1999 Sep; 18(3):357-61. PubMed ID: 10606182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global search for chromosomal abnormalities in infiltrating ductal carcinoma of the breast using array-comparative genomic hybridization.
    Somiari SB; Shriver CD; He J; Parikh K; Jordan R; Hooke J; Hu H; Deyarmin B; Lubert S; Malicki L; Heckman C; Somiari RI
    Cancer Genet Cytogenet; 2004 Dec; 155(2):108-18. PubMed ID: 15571796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translating the genomic architecture of breast cancer into clinical applications.
    Horlings HM; Savci-Heijink CD; van de Vijver MJ
    Sci Transl Med; 2010 Jun; 2(38):38ps32. PubMed ID: 20592419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.